1 / 1

OEM PT-141 10mg Suppliers, Exporter

Size: 10mg Contents: PT-141 Form: Lyophilized powder Purity: 99% customize: Customizable

Send Inquiry

Product Description

Overview

PT-141 (Bremelanotide) is a synthetic peptide that activates melanocortin receptors (MC3/MC4) in the brain. Unlike PDE-5 inhibitors, it works through the central nervous system rather than blood flow. It is FDA-approved for hypoactive sexual desire disorder (HSDD) in women and is commonly used on an on-demand basis.

Reconstitution Instructions

Vial strength: 10 mg lyophilized powder

Draw 3.0 mL of bacteriostatic water.
Slowly inject the water down the side of the vial.
Gently swirl until fully dissolved (do not shake).
Label with name, concentration, and date.
Store refrigerated at 2–8 °C (36–46 °F).

Final concentration: 3.33 mg/mL

On-Demand Dosage Protocol

PT-141 is typically used as needed, not daily.

Purpose	Dose	Volume	U-100 Syringe Units
FDA-recommended dose	1.75 mg (1750 mcg)	0.53 mL	~53 units
Moderate starting dose	1.0 mg (1000 mcg)	0.30 mL	~30 units
Conservative / first-time dose	0.5 mg (500 mcg)	0.15 mL	~15 units

Timing:

Inject 45–60 minutes before desired effect
Maximum: once per day
Limit: no more than 8 injections per month

Syringe & Measurement Notes

Use U-100 insulin syringes
1 unit = 0.01 mL
At 3.33 mg/mL concentration: ≈33.3 mcg per unit

For smaller doses (≤0.15 mL), a 30- or 50-unit syringe improves accuracy.

Administration

Route: Subcutaneous injection
Sites: Abdomen or thigh
Rotate injection sites regularly
Always use sterile syringes and proper disposal methods

Storage Method

State	Storage
Unreconstituted powder	−20 °C (freezer), dry & dark
Reconstituted solution	2–8 °C (refrigerator)
Shelf life (mixed)	Best used within 30 days
Avoid	Repeated freeze-thaw cycles

Common Side Effects

Usually mild and temporary:

Nausea (most common)
Facial flushing
Headache
Temporary increase in blood pressure

Starting at a lower dose can help reduce side effects.

Frequently Asked Questions (FAQ)

Q1: How does PT-141 (Bremelanotide) work differently from traditional options?

Unlike PDE-5 inhibitors that target blood flow, PT-141 works directly through the central nervous system by activating melanocortin receptors (MC3/MC4) in the brain.

Q2: How should PT-141 be reconstituted?

Slowly inject 3.0 mL of bacteriostatic water down the side of a 10 mg vial. Gently swirl until dissolved without shaking. This yields a final concentration of 3.33 mg/mL.

Q3: When should PT-141 be injected and how often?

It should be injected subcutaneously 45–60 minutes before the desired effect. Usage should be limited to a maximum of once per day and no more than 8 injections per month.

Q4: What is the proper way to store PT-141?

Unreconstituted powder should be kept in a freezer at −20 °C (dry & dark). Once reconstituted, store in a refrigerator at 2–8 °C (36–46 °F) and use within 30 days. Avoid repeated freeze-thaw cycles.

Q5: What are the common side effects and how can they be minimized?

Common side effects include mild, temporary nausea, facial flushing, headache, and temporary blood pressure increases. Starting with a lower initial dose (such as 0.5 mg) can help reduce these effects.